pirenzepine has been researched along with Colonic Neoplasms in 2 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
Colonic Neoplasms: Tumors or cancer of the COLON.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kerr, PM | 1 |
| Hillier, K | 1 |
| Wallis, RM | 1 |
| Garland, CJ | 1 |
| Kopp, R | 1 |
| Lambrecht, G | 1 |
| Mutschler, E | 1 |
| Moser, U | 1 |
| Tacke, R | 1 |
| Pfeiffer, A | 1 |
2 other studies available for pirenzepine and Colonic Neoplasms
| Article | Year |
|---|---|
Characterization of muscarinic receptors mediating contractions of circular and longitudinal muscle of human isolated colon.
Topics: Alkaloids; Atropine; Carbachol; Carcinoma; Colon; Colonic Neoplasms; Dose-Response Relationship, Dru | 1995 |
Human HT-29 colon carcinoma cells contain muscarinic M3 receptors coupled to phosphoinositide metabolism.
Topics: Carbachol; Carcinoma; Colonic Neoplasms; Gastric Mucosa; Humans; Inositol Phosphates; Phosphatidylin | 1989 |